Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges
Accelerate Diagnostics | 10-Q: Q3 2024 Earnings Report
Accelerate Diagnostics GAAP EPS of -$0.59 Misses by $0.12, Revenue of $2.98M Misses by $0.02M
Accelerate Diagnostics: Q3 Earnings Snapshot
Accelerate Diagnostics | 8-K: Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
Express News | Accelerate Diagnostics Q3 Net Income USD -14.6 Million
Accelerate Diagnostics 3Q Sales $2.98M >AXDX
Earnings Preview: AXDX to Report Financial Results Post-market on November 07
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
Accelerate Diagnostics Announces FDA Clearance Of Its Accelerate Arc System, An Automated Platform Designed To Fight Against Sepsis And Antimicrobial Resistance
Express News | Accelerate Diagnostics Announces FDA Clearance of Its Accelerate ARC™ System
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
Earnings Call: Accelerate Diagnostics Q2 2024 Results and Wave Program Update
Earnings Call Summary | Accelerate Diagnostics(AXDX.US) Q2 2024 Earnings Conference
Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript
Accelerate Diagnostics | 10-Q: Q2 2024 Earnings Report
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q2 Revenue $3M
No Data
No Data